JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 22 No. 7 606-609
© 1981 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Daniels, D. L.
Right arrow Articles by Henry, H. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Daniels, D. L.
Right arrow Articles by Henry, H. W.

Selective Performance of the T3 Uptake: A Practical Approach to Thyroid Function Studies. Concise Communication

Douglas L. Daniels and Herbert W. Henry

William Beaumont Army Medical Center, El Paso, Texas

Correspondence: For reprints contact: Douglas L. Daniels, Nuclear Medicine Service, William Beaumont Army Medical Center, El Paso, TX 79920.

ABSTRACT

Of 5008 patients with normal serum thyroxine concentrations (T4 = 4.8–12.2 µg/dl) assayed by our laboratory during an 11-mo period, only 41 (0.82%) had an abnormal free thyroxine index (FTI). Narrowing the T4 normal range by 0.5 µg/dl at both ends to create a discriminatory range of 5.3–11.7 µg/dl reduced this number to 13( 0.26%). Evaluation of the medical records for 11 of these 13 patients revealed histories of estrogen and thyroid-hormone administration, individually or in combination, which may have contributed to their divergence from the population. A program for the selective performance of serum T3 uptake (T3U) and FTI determinations only on those sera with T4 concentrations outside of a discriminatory range is described and evaluated. This initial discrimination is the first step in a practical system for selective performance of additional in vitro thyroid function assays to derive maximum diagnostic information from a single patient sample. In our institution the program described is easily adapted to computerization and has resulted in a substantial reduction of reagent costs while providing more efficient utilization of laboratory personnel.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1981 by the Society of Nuclear Medicine.